skip to primary navigationskip to content

Elpis Biomed

Human cells made easy

 

Elpis Biomed aims to become a leading, global supplier of in vitro cell types for academic research and commercial drug discovery & development purposes. The cells could provide an alternative to the limited supply of primary cells and replace animal studies in other cases. Elpis Biomed’s proprietary technology allows rapid generation of highly mature, differentiated cell types at unmatched purity. The process is scalable with the potential to expand product offering with additional cell-types in the neuro-mesoderm focus area. Initial products will be cortical neurons, oligodendrocytes and skeletal muscle cells to be sold to academic research groups and pharma/biotech customers.

Company Information

Year Founded

  • 2016

Website

  • www.elpisbiomed.com

Email

Phone

  • 07554 441860

RSS Feed Latest news

Sparrho Spreads its Wings

Jul 17, 2017

Sparrho raises $3 million to democratize access to science research

Silver Medal Awarded to Breath Biopsy Pioneer Billy Boyle

Jul 04, 2017

Owlstone Medical CEO Billy Boyle wins Royal Academy of Engineering’s Silver Medal

ideaSpace Alumni close three funding deals in a week

Jun 26, 2017

£4.3m raised in an exceptional 7 days for SyndicateRoom

Life sciences equity crowdfunding platform, Capital Cell shortlisted for international award

Jun 23, 2017

Shortlisted for the Best International Growth Business award at the UK Business Angels Association Investment Awards 2017

Addenbrooke's takes over the GeneAdviser ordering platform for genetic testing

Jun 21, 2017

GeneAdviser's platform to live on as in-house NHS tool

View all news